Skip to content

Ischaemic Stroke and Sleep Apnea in Northern Part of Finland

Obstructive Sleep Apnea as a Risk Factor for Ischaemic Stroke , a Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01861275
Enrollment
256
Registered
2013-05-23
Start date
2013-04-30
Completion date
2015-01-31
Last updated
2016-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnoea, Cerebral Palsy

Keywords

osa, cerebral palsy, thrombolysis in cerebral palsy, sleep registration

Brief summary

Obstructive sleep apnoea is a risk factor for ischaemic stroke. study hypothesis: In prospective study the investigators want to know how many ischaemic stroke patients have sleep apnoea and does thrombolysis play a role in severity of osa in six months follow up.

Detailed description

In prospective study the investigators include all over 18 years old patients who came to emergency room for ischaemic stroke. Exclusion criteria is not able to co-operate or need for intensive care unit.The investigators shall take 100 control patients who have ischaemic stroke and no thrombolysis and 100 study patients who will have thrombolysis. The investigators do sleep registration during hospital staying within 2 days after patients have felt ill.Follow-up registration will be done after 6 months at home.

Interventions

Nasal CPAP treatment for obstructive sleep apnoea

Sponsors

University of Oulu
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* over 18 years old patients that have cerebral palsy and are able to participate to the study.

Exclusion criteria

* no co-operation and need for intensive care unit

Design outcomes

Primary

MeasureTime frameDescription
cerebral palsy events and severity of osafrom six months to twenty four monthsin prospective study outcome measure is severity of osa in 6months follow-up

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026